Fate Therapeutics, Inc. (FATE)
NASDAQ: FATE · Real-Time Price · USD
1.975
+0.075 (3.95%)
Jun 10, 2026, 10:11 AM EDT - Market open
Fate Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $7 | Buy | Reiterates | $7 | +254.43% | Jun 8, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $6 | Buy | Reiterates | $6 | +203.80% | Jun 5, 2026 |
| Needham | Needham | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Jun 4, 2026 |
| Bank of America Securities | Bank of America Securities | Hold Reiterates $2 → $2.2 | Hold | Reiterates | $2 → $2.2 | +11.39% | May 22, 2026 |
| Jefferies | Jefferies | Buy Initiates $4 | Buy | Initiates | $4 | +102.53% | May 19, 2026 |
| Wedbush | Wedbush | Buy Maintains $7 | Buy | Maintains | $7 | +254.43% | May 14, 2026 |
Unknown Analyst Wells Fargo No rating | Wells Fargo | Hold Maintains $2.5 | Hold | Maintains | $2.5 | +26.58% | May 14, 2026 |
| TD Cowen | TD Cowen | Hold Maintains n/a | Hold | Maintains | n/a | n/a | May 13, 2026 |